Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy.
APA
Liu R, Meng Y, Rahouma M (2026). Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy.. Frontiers in pharmacology, 17, 1744580. https://doi.org/10.3389/fphar.2026.1744580
MLA
Liu R, et al.. "Editorial: Advancing NSCLC treatment: overcoming challenges in immune checkpoint inhibitor therapy.." Frontiers in pharmacology, vol. 17, 2026, pp. 1744580.
PMID
41971087
같은 제1저자의 인용 많은 논문 (5)
- Mechanistic insights into the roles of astragalosides and polysaccharides in gynecological and breast cancers (Review).
- Recent research progress in structural optimization and cancer treatment of novel selective FGFR inhibitors (2020-2025).
- Predicting cervical lymph node metastasis in papillary thyroid carcinoma using capsule disruption length measured by 3D-US.
- Ginkgolic acid targets HSPA8 to trigger ferroptosis in hepatocellular carcinoma chaperone-mediated autophagy-dependent GPX4 degradation.
- Investigation of a Sc-radiolabelled PDGFRβ-targeted affibody in SPECT imaging and radiotherapy for pancreatic cancer.